COMP <GO>
CME vs HSBC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
CME Group Inc. (NASDAQ) VS. HSBC Holdings plc. (NYSE) • 15-METRIC TALLY: CME 7
— HSBC 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: HSBC
LAST: $303.14 (+2.27%) • MKT CAP: $106.10B
options-implied-move
6.90%
LAST: $85.42 (-1.36%) • MKT CAP: $297.33B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CME VS. HSBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CME | HSBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 9.90% | -6.40 | HSBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.2x | 21.0x | +19.20 | HSBC | /valuation <GO> |
| Free Cash Flow Yield | 3.95% | 2.21% | +1.74 | CME | /fcf-yield <GO> |
| Operating Margin | 64.90% | 13.90% | +51.00 | CME | /operating-margins <GO> |
| Net Profit Margin | 62.50% | 10.90% | +51.60 | CME | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 23.10% | -16.70 | HSBC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.71% | 0.00% | +3.71 | CME | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.55 | 3.74 | -3.19 | HSBC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.90% | 6.60% | +0.30 | HSBC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 25.0 | +40.40 | CME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.92 | +0.09 | CME | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | 27.6x | -3.30 | CME | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $106.10B | $297.33B | -$191.23B | HSBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CME REV | HSBC REV | CME GROSS % | HSBC GROSS % | CME FCF | HSBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.52B | — | 44.0% | — | $4.19B | — |
| FY 2024 | $6.13B | — | 44.0% | — | $3.60B | — |
| FY 2023 | $5.58B | — | 44.0% | — | $3.20B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CME // BETA 1.01
HSBC // BETA 0.92